E2 ModeratePreliminaryPEM ?Case-ControlPeer-reviewedMachine draft
Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome.
Murdoch, J C · The New Zealand medical journal · 1988
Quick Summary
This study tested immune system function in 33 ME/CFS patients compared to 33 healthy people of similar age and sex. Researchers used a skin test device called the multitest CMI to measure how well the immune system responded. They found that ME/CFS patients had weaker immune responses than healthy controls, suggesting their T-cells (a key type of immune cell) may not be working normally.
Why It Matters
This early study provides objective evidence that ME/CFS involves measurable immune system dysfunction, particularly T-cell abnormalities. Identifying immune system problems helps validate ME/CFS as a biological illness and points researchers toward understanding potential disease mechanisms and exploring immune-targeted treatments.
Observed Findings
- Multitest CMI scores were significantly lower in ME/CFS patients than in healthy controls
- T-cell mediated immune response appeared abnormal in the patient group
- 33 patients with ME/CFS were compared to 33 age and sex-matched healthy controls
- The difference in immune measurements between groups was statistically significant
Inferred Conclusions
- ME/CFS patients have a measurable T-cell abnormality detectable by skin-test immunology
- Cell-mediated immunity is impaired in ME/CFS compared to healthy individuals
Remaining Questions
- What is the mechanism underlying the observed T-cell dysfunction in ME/CFS?
- Does immune dysfunction correlate with symptom severity or disease duration?
- Are immune abnormalities persistent over time or do they fluctuate?
- Which specific T-cell subsets or functions are most impaired in ME/CFS patients?
What This Study Does Not Prove
This study does not prove that T-cell abnormalities cause ME/CFS—only that an association exists. It does not establish whether immune dysfunction is primary to the disease, secondary to chronic illness, or related to other factors like viral infections or stress. The small sample size and single timepoint measurement limit generalizability and do not show whether immune markers change over time or correlate with symptom severity.
Tags
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionSmall Sample
Metadata
- PMID
- 3261407
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026